This compound is a chemical compound used as a pharmaceutical intermediate. Its primary significance is in the manufacturing process for osimertinib, an active pharmaceutical ingredient.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 1421372-94-2
N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro-1,4-benzenediamine
pharmaceutical intermediate
4-Fluoro-2-methoxy-5-nitroaniline
pharmaceutical intermediate for osimertinib
2-Bromo-4-fluorotoluene
Pharmaceutical intermediate for synthesis
(1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol
Pharmaceutical intermediate
(1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol
entecavir intermediate
(3R,4S)-3-FLUOROOXAN-4-OL
Pharmaceutical intermediate for drug synthesis
Mutated EGFR-IN-1
EGFR inhibitor research compound
N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methylindol-3-yl)pyrimidin-2-amine
SZTYQQYYIMVETL-UHFFFAOYSA-N
CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=CC(=C(C=C4OC)F)[N+](=O)[O-]